RecruitingNot ApplicableNCT05855668
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
Sponsor
Centre for Addiction and Mental Health
Enrollment
400 participants
Start Date
Nov 10, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This 2-arm study will recruit participants with 1) alcohol use disorder and 2) cannabis use disorder for a 12-week cognitive behavioral therapy, following a thorough baseline assessments on executive function, incentive salience, and negative emotionality.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Patient has been referred to or intends to participate in either the AUD or CUD Integrated Care Pathway (and is therefore willing to participate in group psychotherapy).
- Able to communicate and provide informed consent in English.
- years of age or older.
- Willing and able to safely abstain from substances (other than nicotine or tobacco products), including alcohol and cannabis, for 12 hours prior to the eligibility and task-based assessments.
- Meets DSM-5 diagnostic criteria for AUD (AUD group) or CUD (CUD group)
- Meets criteria for risky drinking, defined as \> 10 drinks per week for females and \> 15 drinks per week for males on average over the past 30 days (AUD group) or daily or near-daily cannabis use over the past 30 days, defined as ≥ 4 days of cannabis use per week on average (CUD group)
Exclusion Criteria5
- Active suicidal ideation at time of assessment.
- Suicide attempt within the past month.
- Unstable psychiatric or medical status (e.g., acute psychosis or mania) or unstable use of another substance that may interfere with participation in groups (e.g. active fentanyl use).
- Enrollment in another study that conflicts with the procedures or scientific integrity of this study.
- Individuals planning to be out of the province for a substantial amount of time during the treatment period will not be permitted to enroll.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALCBT
12 weeks of group CBT for AUD or CUD
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05855668
Related Trials
Tirzepatide in MetALD
NCT070468191 location
Cannabis-Tobacco Co-Use Treatment Study
NCT068831621 location
Environment and Alcohol: A Pilot Study
NCT068606071 location
Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship
NCT057861571 location
NIAAA Natural History Protocol
NCT022318401 location